Close
CDMO Safety Testing 2026
Novotech

Digital Science welcomes Gigantum and Ripeta to the family to help increase reproducibility in research

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.

Quantum Sensors Enabling Advanced Drug Diagnostics

The landscape of medical diagnostics is being reshaped by the introduction of sensing technologies that operate with atomic-level sensitivity. By providing high-fidelity measurements and real-time data, these tools allow for the detection of subtle biological changes and chemical markers that were previously invisible to conventional equipment. This advancement is enhancing the precision of drug testing and clinical monitoring, leading to earlier disease detection and more effective therapeutic interventions across the global healthcare spectrum.

Quantum Computing Optimizing Pharma Supply Chains

The global distribution of pharmaceutical products is facing unprecedented challenges that demand a new level of logistical precision and resilience. By utilizing advanced analytical models, companies can now navigate complex international networks with greater efficiency, ensuring that temperature-sensitive medicines and life-saving therapies reach their destinations without delay. This evolution toward a more intelligent and responsive supply chain is critical for maintaining public health and responding effectively to emerging medical needs on a global scale.
- Advertisement -

Digital Science, a technology company serving stakeholders across the research ecosystem, welcomes two US-based startups to the Digital Science family of companies: automated reproducibility assessment tool, Ripeta, and data science platform, Gigantum.

Both companies are playing a key role in making scientific research reproducible and more transparent. Ripeta is developing a “credit report” for scientific publications to assess and help improve the transparency needed to effectively communicate research, while Gigantum is an emerging innovator in the area of data science platforms, supporting large-scale, data-oriented scientific research.

Daniel Hook, CEO of Digital Science, said: “Reproducibility of research is one of the critical topics of modern times – if research is to remain trusted by the populations who fund it, then researchers must ensure that their research can be reproduced by others.”

Ripeta
Ripeta, a previous Digital Science Catalyst grant winner, aims to make better science easier by identifying and highlighting the important parts of research that should be transparently presented in a manuscript and other materials. The tool detects the key evidence for and assesses reproducibility in the scientific research industry through software and analytics development; improving evidence-based science and fiscal efficiency of research investments. These tools leverage sophisticated machine-learning and natural language processing algorithms to extract key reproducibility elements from research articles.

Ripeta focuses on assessing the quality of the reporting and robustness of the scientific method rather than the quality of the science. The companyโ€™s long-term goal includes developing a suite of tools across the broader spectrum of sciences to understand and measure the key standards and limitations for scientific reproducibility across the research lifecycle and enable an automated approach to their assessment and dissemination.

Leslie McIntosh, CEO of Ripeta, said: “While technological innovations have accelerated scientific discoveries, they have complicated scientific reporting. Science is hard and reproducibility is important, so we need to make better science easier.

“We are developing the tools to make research methods transparent, enabling the verifiability, falsifiability and reproducibility of research. We are thrilled to receive this investment with the great team at Digital Science who provide a fantastic partnership. This will propel our work at Ripeta helping make scientific reporting more transparent.”

Gigantum
Gigantum is a completely new approach to handling the interaction between code, data and run-time environments in this new data-rich research world. Focused on open-source tools and frameworks, Gigantum helps researchers to better scale the creation, management and dissemination of fully reproducible research and the data science that supports it.

Gigantum seeks to develop a platform that keeps pace with the expanding number of independently created tools and data sources, thereby serving an increasingly diverse but collaborative set of researchers with non-uniform skills, interests, and resources. The teamโ€™s technical approach is based on their appreciation that the automated management of data, code, environment, and version history is fundamental to enabling decentralized collaboration.

Dean Kleissas, Gigantum CTO, said: “Despite wide adoption of open-source tools and growing willingness to share research code and data, we still canโ€™t quite escape the evolving difficulties of publishing transparent and easily reproducible research for broad use and consumption.

“When we first spoke with Digital Science, I knew it was a good fit because we immediately clicked on the fact that best practices alone wonโ€™t do it. We need technological approaches that enable real changes in what people of all skill levels can do, not just the most skilled.”

Reproducibility
“Gigantum and Ripeta together address two of the biggest aspects of reproducibility: workflow and communication. Through Gigantum, a researcher can ensure that they have the full provenance of the data objects that appear in their papers, allowing anyone to repeat their data processing and analysis with ease,” adds Hook.

“With Ripeta, a researcher is able to check that they have correctly described and referred to the data, methodology and analysis approaches that underpin their arguments.”

About Digital Science
Digital Science is a technology company working to make research more efficient. We invest in, nurture and support innovative businesses and technologies that make all parts of the research process more open and effective. Our portfolio includes admired brands including Altmetric, Anywhere Access, Dimensions, Figshare, ReadCube, Symplectic, IFI Claims, GRID, Overleaf, Labguru, BioRAFT, TetraScience, Transcriptic and CC Technology. We believe that together, we can help researchers make a difference. Visit www.digital-science.com


About Gigantum
Gigantum is a Washington, DC-based company that is developing a decentralized, scalable and user-friendly data science platform that solves outstanding collaboration and reproducibility problems for both producers and consumers of scientific research. The Gigantum Platform combines a user-friendly open source work environment with a scalable cloud-based publishing platform, allowing researchers to work locally but share globally with a single click. Visit www.gigantum.com


About Ripeta
Ripeta detects and predicts reproducibility in the scientific research industry through software and analytics development; improving evidence-based science and fiscal efficiency of research investments. It is effectively a โ€˜credit reportโ€™ for scientific publications. Ripeta provides a suite of tools and services to rapidly screen and assesses manuscripts for the proper reporting of scientific method components. These tools leverage sophisticated machine-learning and natural language processing algorithms to extract key reproducibility elements from research articles. Visit https://www.ripeta.com/

Latest stories

Related stories

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.

Quantum Sensors Enabling Advanced Drug Diagnostics

The landscape of medical diagnostics is being reshaped by the introduction of sensing technologies that operate with atomic-level sensitivity. By providing high-fidelity measurements and real-time data, these tools allow for the detection of subtle biological changes and chemical markers that were previously invisible to conventional equipment. This advancement is enhancing the precision of drug testing and clinical monitoring, leading to earlier disease detection and more effective therapeutic interventions across the global healthcare spectrum.

Quantum Computing Optimizing Pharma Supply Chains

The global distribution of pharmaceutical products is facing unprecedented challenges that demand a new level of logistical precision and resilience. By utilizing advanced analytical models, companies can now navigate complex international networks with greater efficiency, ensuring that temperature-sensitive medicines and life-saving therapies reach their destinations without delay. This evolution toward a more intelligent and responsive supply chain is critical for maintaining public health and responding effectively to emerging medical needs on a global scale.

Quantum security strengthening pharma data protection

Protecting sensitive patient information and proprietary research data is becoming a critical priority as the pharmaceutical industry navigates an increasingly complex digital landscape. By integrating advanced cryptographic methods and secure communication protocols, researchers can ensure the integrity of their clinical findings and the privacy of those involved in medical trials. This shift toward a more resilient digital infrastructure is essential for maintaining public trust and fostering global collaboration in the pursuit of life-saving therapeutic breakthroughs.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป